Thioridazine 2-Sulfone (CAS 14759-06-9)
QUICK LINKS
Thioridazine 2-Sulfone is a compound may function as a potent inhibitor of dopamine receptors. It exerts its mechanism of action by binding to the dopamine receptors and blocking the transmission of dopamine signals within the central nervous system. This interference with dopamine signaling leads to alterations in neurotransmission and modulation of neuronal activity. Thioridazine 2-Sulfone′s mechanism of action involves disrupting the normal functioning of dopamine receptors, thereby affecting the balance of neurotransmitters in the brain. Thioridazine 2-Sulfone′s functional role in experimental applications lies in its ability to target and modulate dopamine receptors, which may be useful to investigate the role of dopamine signaling in various physiological and pathological processes. Its mechanism of action at the molecular level allows for the study of dopamine receptor function and its implications in neurobiological research.
Thioridazine 2-Sulfone (CAS 14759-06-9) References
- Racemization and degradation of thioridazine and thioridazine 2-sulfone in human plasma and aqueous solutions. | Masetto de Gaitani, C., et al. 2003. Chirality. 15: 479-85. PMID: 12774286
- Electrocardiogram and cardiovascular changes in thioridazine and chlorpromazine poisoning. | Strachan, EM., et al. 2004. Eur J Clin Pharmacol. 60: 541-5. PMID: 15372128
- Degradation and configurational changes of thioridazine 2-sulfoxide. | de Gaitani, CM., et al. 2004. J Pharm Biomed Anal. 36: 601-7. PMID: 15522536
- Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses. | Salih, IS., et al. 2007. Clin Pharmacol Ther. 82: 548-54. PMID: 17410120
- Endophytic fungi as models for the stereoselective biotransformation of thioridazine. | Borges, KB., et al. 2007. Appl Microbiol Biotechnol. 77: 669-74. PMID: 17876580
- Flow-injection on-line oxidizing fluorimetry and solid phase extraction for determination of thioridazine hydrochloride in human plasma. | Zhang, ZQ., et al. 2007. Talanta. 71: 2056-61. PMID: 19071563
- Assignment of the absolute configuration at the sulfur atom of thioridazine metabolites by the analysis of their chiroptical properties: the case of thioridazine 2-sulfoxide. | Bertucci, C., et al. 2010. J Pharm Biomed Anal. 52: 796-801. PMID: 20376912
- Thioridazine: the good and the bad. | Thanacoody, RH. 2011. Recent Pat Antiinfect Drug Discov. 6: 92-8. PMID: 21548877
- A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia. | Aslostovar, L., et al. 2018. Blood Adv. 2: 1935-1945. PMID: 30093531
- An optical sensor with specific binding sites for the detection of thioridazine hydrochloride based on ZnO-QDs coated with molecularly imprinted polymer. | Ensafi, AA., et al. 2019. Spectrochim Acta A Mol Biomol Spectrosc. 206: 460-465. PMID: 30172874
- Cardiotoxicity of thioridazine and two stereoisomeric forms of thioridazine 5-sulfoxide in the isolated perfused rat heart. | Hale, PW. and Poklis, A. 1986. Toxicol Appl Pharmacol. 86: 44-55. PMID: 3764935
- Simultaneous determination of thioridazine and its S-oxidized and N-demethylated metabolites using high-performance liquid-chromatography on radially compressed silica. | Kilts, CD., et al. 1982. J Chromatogr. 231: 377-91. PMID: 6290516
- Thioridazine and its metabolites in post mortem blood, including two stereoisomeric ring sulfoxides. | Poklis, A., et al. 1982. J Anal Toxicol. 6: 250-2. PMID: 7176556
- Determination of the enantiomers of thioridazine, thioridazine 2-sulfone, and of the isomeric pairs of thioridazine 2-sulfoxide and thioridazine 5-sulfoxide in human plasma. | Eap, CB., et al. 1995. J Chromatogr B Biomed Appl. 669: 271-9. PMID: 7581903
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Thioridazine 2-Sulfone, 5 mg | sc-213036 | 5 mg | $450.00 |